Human Metabolome Technologies Inc

TSE:6090 (Japan)  
円 662.00 (+1.53%) May 15
13.85
P/B:
2.21
Market Cap:
円 3.92B ($ 25.29M)
Enterprise V:
円 2.71B ($ 17.50M)
Volume:
6.50K
Avg Vol (2M):
6.97K
Warning! GuruFocus detected 1 Severe warning sign with 6090. Try a 7-Day Free Trial to check it out.
Volume:
6.50K
Market Cap 円:
3.92B
Market Cap $:
25.29M
13.85
Avg Vol (2M):
6.97K
Enterprise Value 円:
2.71B
Enterprise Value $:
17.50M
PB Ratio:
2.21
Alerts Website Sources Stock PDF
Dataset
Financial Download P  Manual of Stocks™

Business Description

Human Metabolome Technologies Inc

ISIN : JP3794530000
http://www.humanmetabolome.com
Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052
Compare
Compare
TSE:2397TSE:3386TSE:7707TMODHRSHSE:603259IDXXIQVAXSWX:LONNMTDICLRILMNLHDGXWATXPAR:BIMEXASRVTYXPAR:ERF
Traded in other countries / regions
6090.Japan
IPO Date
2013-12-24
Description
Human Metabolome Technologies, Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.

Financial Strength

8/10
Name Current Vs Industry Vs History
Cash-To-Debt 6.5
Equity-to-Asset 0.8
Debt-to-Equity 0.12
Debt-to-EBITDA 0.92
Interest Coverage 95.9
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.13
Distress
Grey
Safe
Beneish M-Score -2.29
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

7/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 13.3
3-Year Book Growth Rate 0.9

Momentum Rank

4/10
Name Current Vs Industry Vs History
5-Day RSI 75.45
9-Day RSI 59.88
14-Day RSI 54.9
6-1 Month Momentum % 1.32
12-1 Month Momentum % -4.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.36
Quick Ratio 4.27
Cash Ratio 3.46
Days Inventory 26.02
Days Sales Outstanding 64.53
Days Payable 7.64

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 1.51
Dividend Payout Ratio 0.22
Forward Dividend Yield % 4.53
5-Year Yield-on-Cost % 1.53
3-Year Average Share Buyback Ratio -0.3
Shareholder Yield % 1.84

Profitability Rank

3/10
Name Current Vs Industry Vs History
Gross Margin % 65.03
Operating Margin % 15
Net Margin % 21.39
FCF Margin % 13.46
ROE % 16.69
ROA % 13.03
ROIC % 31.06
ROC (Joel Greenblatt) % 69.88
ROCE % 13.84
Years of Profitability over Past 10-Year 3

GF Value Rank

8/10
Name Current Vs Industry Vs History
PE Ratio 13.85
PE Ratio without NRI 14.62
Price-to-Owner-Earnings 11.71
PS Ratio 2.96
PB Ratio 2.21
Price-to-Tangible-Book 2.24
Price-to-Free-Cash-Flow 21.96
Price-to-Operating-Cash-Flow 12.05
EV-to-EBIT 11.39
EV-to-EBITDA 11.39
EV-to-Revenue 2.05
EV-to-FCF 14.54
Price-to-Projected-FCF 6.64
Price-to-Median-PS-Value 0.47
Price-to-Graham-Number 1.21
Price-to-Net-Current-Asset-Value 2.88
Price-to-Net-Cash 3.95
Earnings Yield (Greenblatt) % 8.78
FCF Yield % 4.54

Financials

TSE:6090's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Human Metabolome Technologies Inc Executives

Details

GF Value: 円785.09

TSE:6090

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 1,321.621
EPS (TTM) (円) 47.816
Beta 0.4
Volatility % 13.91
14-Day RSI 54.9
14-Day ATR (円) 11.109062
20-Day SMA (円) 659.2
12-1 Month Momentum % -4.03
52-Week Range (円) 588 - 794
Shares Outstanding (Mil) 5.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Human Metabolome Technologies Inc Filings

Filing Date Document Date Form
No Filing Data

Human Metabolome Technologies Inc Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Human Metabolome Technologies Inc Frequently Asked Questions

What is Human Metabolome Technologies Inc(TSE:6090)'s stock price today?
The current price of TSE:6090 is 円662.00. The 52 week high of TSE:6090 is 円794.00 and 52 week low is 円588.00.
When is next earnings date of Human Metabolome Technologies Inc(TSE:6090)?
The next earnings date of Human Metabolome Technologies Inc(TSE:6090) is .
Does Human Metabolome Technologies Inc(TSE:6090) pay dividends? If so, how much?
The  Dividend Yield %  of Human Metabolome Technologies Inc(TSE:6090) is 1.51% (As of Today), Highest Dividend Payout Ratio of Human Metabolome Technologies Inc(TSE:6090) was 0.22. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Human Metabolome Technologies Inc(TSE:6090) is 4.53%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.